Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways

Sriram Sriperumbuduri, Rachel W Khan, Soyeb Aftab, Swapnil Hiremath, Dave Dixon, Gaurav Gupta

Open source

DOI
10.1093/ajh/hpag111
Published
2026-09-08
Container
American Journal of Hypertension
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ajh/hpag111,
  title = {Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways},
  author = {Sriram Sriperumbuduri and Rachel W Khan and Soyeb Aftab and Swapnil Hiremath and Dave Dixon and Gaurav Gupta},
  year = {2026},
  journal = {American Journal of Hypertension},
  doi = {10.1093/ajh/hpag111},
  url = {https://doi.org/10.1093/ajh/hpag111}
}

RIS

TY  - JOUR
TI  - Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways
AU  - Sriram Sriperumbuduri
AU  - Rachel W Khan
AU  - Soyeb Aftab
AU  - Swapnil Hiremath
AU  - Dave Dixon
AU  - Gaurav Gupta
PY  - 2026
JO  - American Journal of Hypertension
DO  - 10.1093/ajh/hpag111
UR  - https://doi.org/10.1093/ajh/hpag111
ER  - 

APA

Sriperumbuduri, S., Khan, R. W., Aftab, S., Hiremath, S., Dixon, D., & Gupta, G. (2026). Antihypertensive Pharmacotherapy in Chronic Kidney Disease: Integrating eGFR-Based Cutoffs, Mechanistic Insights, and Emerging Therapeutic Pathways. American Journal of Hypertension. https://doi.org/10.1093/ajh/hpag111

Source records